Novo Biosciences
A pharmaceutical company that uses a zebrafish drug-screening platform to find drug candidate molecules that have the capacity to promote regeneration of tissues. Their drug candidate MSI-1436 is being developed and tested for the treatment of heart disease, Duchenne Muscular Dystrophy and diabetic nephropathy.
1
Funding Rounds
$4.0m
Money raised
Overview
A pharmaceutical company that uses a zebrafish drug-screening platform to find drug candidate molecules that have the capacity to promote regeneration of tissues. Their drug candidate MSI-1436 is being developed and tested for the treatment of heart disease, Duchenne Muscular Dystrophy and diabetic nephropathy.
- Website:
- Business model: B2B
| Name | Phone | Social networks | |
|---|---|---|---|
| Ke*** St***** | - | - | - |
| Vo** Yi* | - | - | - |
Industries
Novo Biosciences is active in the following industries: